NIH Awards $13M to UCSD-led Consortium for Autism Stem Cell Assays | GenomeWeb

NEW YORK (GenomeWeb) – The National Institutes of Health has awarded a five-year, $13 million grant to a public-private research consortium to develop and disseminate stem cell-based technologies and assays to study autism spectrum disorder and other mental health diseases.

Gene Yeo, an associate professor of cellular and molecular medicine at the University of California, San Diego School of Medicine, and a founding member of the Institute for Genomic Medicine, is principal investigator on the project.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.